Safety and efficacy of high-dose daptomycin as salvage therapy for severe gram-positive bacterial sepsis in hospitalized adult patients

Daptomycin Versus Vancomycin for Bloodstream Infections Due to Methicillin-Resistant Staphylococcus aureus With a High Vancomycin Minimum Inhibitory Concentration: A Case-Control Study

(2011) C. L. Moore et al.   CLINICAL INFECTIOUS DISEASES

Daptomycin: evaluation of a high-dose treatment strategy

(2011) Gary Wu et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Safety and efficacy of daptomycin for the treatment of hospitalized adult patients in Taiwan with severe staphylococcal infections

(2011) Chung-Chih Lai et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

High-Dose Daptomycin for Treatment of Complicated Gram-Positive Infections: A Large, Multicenter, Retrospective Study

(2011) Ravina Kullar et al.   PHARMACOTHERAPY

Acute Eosinophilic Pneumonia Secondary to Daptomycin: A Report of Three Cases

(2010) Becky A. Miller et al.   CLINICAL INFECTIOUS DISEASES

Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis

(2010) Sujata M. Bhavnani et al.   CLINICAL INFECTIOUS DISEASES

High-dose daptomycin in documented Staphylococcus aureus infections

(2010) Matteo Bassetti et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

High and Increasing Oxa-51 DNA Load Predict Mortality in Acinetobacter baumannii Bacteremia: Implication for Pathogenesis and Evaluation of Therapy

(2010) Yu-Chung Chuang et al.   PLoS One

Safety and Clinical Outcomes when Utilizing High-Dose (≥8 mg/kg) Daptomycin Therapy

(2009) Pamela A Moise et al.   ANNALS OF PHARMACOTHERAPY

Relationship between Susceptibility to Daptomycin In Vitro and Activity In Vivo in a Rabbit Model of Aortic Valve Endocarditis

(2009) H. F. Chambers et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics and Safety of Multiple Intravenous Doses of Daptomycin in a Taiwanese Adult Population

(2009) Shiou-Haur Liang et al.   CHEMOTHERAPY

Safety of High‐Dose Intravenous Daptomycin Treatment: Three‐Year Cumulative Experience in a Clinical Program

(2009) D. A. Figueroa et al.   CLINICAL INFECTIOUS DISEASES

Severity of illness scoring systems in patients with bacteraemic pneumococcal pneumonia: implications for the intensive care unit care

(2009) C. Feldman et al.   CLINICAL MICROBIOLOGY AND INFECTION

High-dose daptomycin for the treatment of endocarditis caused by Staphylococcus aureus with intermediate susceptibility to glycopeptides

(2009) Mathias Lichterfeld et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

International Study of the Prevalence and Outcomes of Infection in Intensive Care Units

(2009) Jean-Louis Vincent   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prevalence of and Risk Factors for Colonization by Methicillin-Resistant Staphylococcus aureus among Adults in Community Settings in Taiwan

(2009) J.-T. Wang et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Evaluation of Daptomycin Pharmacodynamics and Resistance at Various Dosage Regimens against Staphylococcus aureus Isolates with Reduced Susceptibilities to Daptomycin in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations

(2008) W. E. Rose et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High rate of decreasing daptomycin susceptibility during the treatment of persistent Staphylococcus aureus bacteremia

(2008) M. Sharma et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria

(2008) D. E. Katz et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Bacteremia and Infective Endocarditis Caused by a Non-Daptomycin-Susceptible, Vancomycin-Intermediate, and Methicillin-Resistant Staphylococcus aureus Strain in Taiwan

(2008) Y.-T. Huang et al.   JOURNAL OF CLINICAL MICROBIOLOGY